These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8864460)

  • 1. Successful treatment of severe hepatic veno-occlusive disease after allogeneic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS).
    Lévy V; Azoulay D; Rio B; Vincent F; Rabbat A; Hunault M; Bazarbachi A; Delmer A; Zittoun R
    Bone Marrow Transplant; 1996 Aug; 18(2):443-45. PubMed ID: 8864460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation.
    Azoulay D; Castaing D; Lemoine A; Hargreaves GM; Bismuth H
    Bone Marrow Transplant; 2000 May; 25(9):987-92. PubMed ID: 10800068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of hepatic veno-occlusive disease in a peripheral blood progenitor cell transplant patient with a transjugular intrahepatic portosystemic stent-shunt (TIPS).
    de la Rubia J; Carral A; Montes H; Urquijo JJ; Sanz GF; Sanz MA
    Haematologica; 1996; 81(6):536-9. PubMed ID: 9009442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant.
    Rapoport AP; Doyle HR; Starzl T; Rowe JM; Doeblin T; DiPersio JF
    Bone Marrow Transplant; 1991 Nov; 8(5):421-4. PubMed ID: 1768978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease.
    Smith FO; Johnson MS; Scherer LR; Faught P; Breitfeld PP; Albright E; Hillier SC; Gowan D; Smith PD; Robertson KA; Emanuel D
    Bone Marrow Transplant; 1996 Sep; 18(3):643-6. PubMed ID: 8879632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation.
    Fried MW; Connaghan DG; Sharma S; Martin LG; Devine S; Holland K; Zuckerman A; Kaufman S; Wingard J; Boyer TD
    Hepatology; 1996 Sep; 24(3):588-91. PubMed ID: 8781329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.
    Azoulay D; Castaing D; Lemoine A; Samuel D; Majno P; Reynes M; Charpentier B; Bismuth H
    Clin Nephrol; 1998 Aug; 50(2):118-22. PubMed ID: 9725784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIPS for veno-occlusive disease following stem cell transplantation.
    Schoppmeyer K; Lange T; Wittekind C; Niederwieser D; Caca K
    Z Gastroenterol; 2006 Jun; 44(6):483-6. PubMed ID: 16773513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt.
    Senzolo M; Patch D; Cholongitas E; Triantos C; Marelli L; Stigliano R; Dhillon A; Burroughs A
    Transplantation; 2006 Jul; 82(1):132-5. PubMed ID: 16861953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous intrahepatic portosystemic shunting in the treatment of veno-occlusive disease of the liver after bone marrow transplantation].
    Alvarez R; Bañares R; Casariego J; Echenagusía A; Simó G; Alvarez E; Serrano D; Díez-Martín JL
    Gastroenterol Hepatol; 2000 Apr; 23(4):177-80. PubMed ID: 10863859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS).
    Zenz T; Rössle M; Bertz H; Siegerstetter V; Ochs A; Finke J
    Liver; 2001 Feb; 21(1):31-6. PubMed ID: 11169070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.
    Schlitt HJ; Tischler HJ; Ringe B; Raddatz G; Maschek H; Dietrich H; Kuse E; Pichlmayr R; Link H
    Bone Marrow Transplant; 1995 Sep; 16(3):473-8. PubMed ID: 8535323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the use of transjugular intrahepatic portosystemic shunts for veno-occlusive disease.
    Rajvanshi P; McDonald GB
    Liver Transpl; 2001 Feb; 7(2):154-7. PubMed ID: 11172402
    [No Abstract]   [Full Text] [Related]  

  • 14. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
    Gómez-Centurión I; Bailén R; Oarbeascoa G; Muñoz C; Luque AÁ; Boyra ME; Calleja E; Rincón D; Dorado N; Barzallo P; Anguita J; Díez-Martín JL; Kwon M
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2089-2097. PubMed ID: 32791193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The veno-occlusive disease of the liver.
    Baron F; Deprez M; Beguin Y
    Haematologica; 1997; 82(6):718-25. PubMed ID: 9499675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of veno-occlusive disease with recombinant tissue plasminogen activator in a patient requiring peritoneal dialysis.
    Simpson DR; Browett PJ; Doak PB; Palmer SJ
    Bone Marrow Transplant; 1994 Oct; 14(4):635-6. PubMed ID: 7858540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A trial use of prostaglandin E1 for prevention of hepatic veno-occlusive disease after allogeneic bone marrow transplantation].
    Morio S; Oh H; Kogure K; Ishii H; Ishii A; Nakaseko C; Ikegami T; Kawano E; Matsuura Y; Nishimura M
    Rinsho Ketsueki; 1994 Sep; 35(9):846-52. PubMed ID: 7967053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Veno-occlusive disease of the liver].
    Rybicka M; Krysiak R; Okopień B
    Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.
    Hasegawa S; Horibe K; Kawabe T; Kato K; Kojima S; Matsuyama T; Hirabayashi N
    Bone Marrow Transplant; 1998 Dec; 22(12):1191-7. PubMed ID: 9894723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.